Picture of Agenus logo

AGEN Agenus Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Agenus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-183-28.7-231-257-232
Depreciation
Non-Cash Items27.741.824.38.8928
Unusual Items
Other Non-Cash Items
Changes in Working Capital8.95-9.7424.110.832.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-13910.1-175-224-158
Capital Expenditures-3.47-33.8-53.1-9.95-0.576
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.975-9.3419.513.40.603
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-4.44-43.1-33.63.40.027
Financing Cash Flow Items-1.540079.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18422595.8120123
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash40.7192-113-102-35.7